FDA replaces Makary with pro-industry commissioner by August 2027

After Makary's departure, the Trump administration nominates a mainstream, pro-industry figure like Stephen Hahn or Kyle Diamantas. This signals a shift toward lighter regulatory burdens for pharmaceutical companies.

Implied probability (Yes)

60%

Closes

2027-12-31